The Latin America, Middle East and Africa Inhaled Nitric Oxide Market would witness market growth of 8.5% CAGR during the forecast period (2020-2026). Inhaled Nitric Oxide acts as a pulmonary vasodilator that helps in controlling vascular muscle tone.
The field of Nitric Oxide has evolved during the last century, to embed various fields of bio-medical research due to its acknowledgment as a prime endothelial-derived vasodilator molecule. Presently, Nitric Oxide acts as an important signalling molecule all over the body.
The inhaled nitric oxide market is expected to increase over the forecast period due to the increasing prevalence of respiratory diseases, the increasing number of breathing problems in infants, and the initiatives by the FDA to motivate clinical use of inhaled nitric oxide. Additionally, technological improvements in inhaled nitric oxide and the latest product introduced by the companies operating in the market are anticipated to offer lucrative opportunities over the forecast period.
Nitric oxide, at room temperature, is a colorless and odorless gas that is soluble in water. Although there are many advantages of nitric oxide, but the potential therapeutic value of inhaled nitric oxide is uncertain in adults & authorized indications are limited to pediatric practice. Moreover, there is some recent modification in the marketing of the inhaled nitric oxide, has added to the cost of nitric oxide treatment. Inhaled nitric oxide is a therapeutic therapy with broad capabilities for pediatric clinical usage.
Based on Application, the market is segmented into Neonatal Respiratory Treatment, Chronic Obstructive Pulmonary Disease (COPD), Acute Respiratory Distress Syndrome (ARDS) and Other Applications. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The Neonatal Respiratory Treatment market dominated the South Africa Inhaled Nitric Oxide Market by Application in 2019, thereby, achieving a market value of $5.8 Million by 2026. The Chronic Obstructive Pulmonary Disease (COPD) market is showcasing a CAGR of 9.6% during (2020 - 2026).
Free Valuable Insights: Inhaled Nitric Oxide Market in LAMEA is expected to register a CAGR of 8.5% during the forecast period (2020-2026)
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Getinge AB, Merck Group, Halma PLC, Linde PLC (Praxair, Inc.), Air Liquide S.A., Beyond Air, Inc., Mallinckrodt PLC (International Minerals and Chemical Corporation), VERO Biotech LLC, Nu-Med Plus, Inc. and Novoteris, LLC.
Scope of the Study
Market Segments Covered in the Report:
By Application
- Neonatal Respiratory Treatment
- Chronic Obstructive Pulmonary Disease (COPD)
- Acute Respiratory Distress Syndrome (ARDS)
- Other Applications
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Getinge AB
- Merck Group
- Halma PLC
- Linde PLC (Praxair, Inc.)
- Air Liquide S.A.
- Beyond Air, Inc.
- Mallinckrodt PLC (International Minerals and Chemical Corporation)
- VERO Biotech LLC
- Nu-Med Plus, Inc.
- Novoteris, LLC
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Inhaled Nitric Oxide Market, by Application
1.4.2 LAMEA Inhaled Nitric Oxide Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market composition
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies deployed in Inhaled Nitric Oxide Market - Global
Chapter 4. LAMEA Inhaled Nitric Oxide Market by Application
4.1 LAMEA Neonatal Respiratory Treatment Repellent Market by Country
4.2 LAMEA Chronic Obstructive Pulmonary Disease (COPD) Repellent Market by Country
4.3 LAMEA Acute Respiratory Distress Syndrome (ARDS) Market by Country
4.4 LAMEA Other Applications Market by Country
Chapter 5. LAMEA Inhaled Nitric Oxide Market by Country
5.1 Brazil Inhaled Nitric Oxide Market
5.1.1 Brazil Inhaled Nitric Oxide Market by Application
5.2 Argentina Inhaled Nitric Oxide Market
5.2.1 Argentina Inhaled Nitric Oxide Market by Application
5.3 UAE Inhaled Nitric Oxide Market
5.3.1 UAE Inhaled Nitric Oxide Market by Application
5.4 Saudi Arabia Inhaled Nitric Oxide Market
5.4.1 Saudi Arabia Inhaled Nitric Oxide Market by Application
5.5 South Africa Inhaled Nitric Oxide Market
5.5.1 South Africa Inhaled Nitric Oxide Market by Application
5.6 Nigeria Inhaled Nitric Oxide Market
5.6.1 Nigeria Inhaled Nitric Oxide Market by Application
5.7 Rest of LAMEA Inhaled Nitric Oxide Market
5.7.1 Rest of LAMEA Inhaled Nitric Oxide Market by Application
Chapter 6. Company Profiles
6.1 Getinge AB
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Regional Analysis
6.1.4 Research & Development Expense
6.2 Merck Group
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.3 Halma PLC
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.4 Linde PLC (Praxair, Inc.)
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Regional Analysis
6.4.4 Research & Development Expense
6.4.5 Recent strategies and developments:
6.4.5.1 Acquisition and Mergers:
6.5 Air Liquide S.A.
6.5.1 Company Overview
6.5.1 Financial Analysis
6.6 Beyond Air, Inc.
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Research & Development Expense
6.6.4 Recent strategies and developments:
6.6.4.1 Trials and Approvals:
6.7 Mallinckrodt PLC (International Minerals and Chemical Corporation)
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Segmental and Regional Analysis
6.7.4 Research & Development Expense
6.7.5 Recent strategies and developments:
6.7.5.1 Trials and Approvals:
6.7.5.2 Partnerships, Collaborations, and Agreements:
6.8 VERO Biotech LLC
6.8.1 Company Overview
6.8.2 Recent strategies and developments:
6.8.2.1 Trials and Approvals:
6.9 Nu-Med Plus, Inc.
6.9.1 Company Overview
6.9.2 Recent strategies and developments:
6.9.2.1 Partnerships, Collaborations, and Agreements:
6.10. Novoteris, LLC
6.10.1 Company Overview
6.10.2 Recent strategies and developments:
6.10.2.1 Trials and Approvals:
TABLE 1 LAMEA Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
TABLE 2 LAMEA Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
TABLE 3 LAMEA Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
TABLE 4 LAMEA Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
TABLE 5 LAMEA Neonatal Respiratory Treatment Repellent Market by Country, 2016 - 2019, USD Million
TABLE 6 LAMEA Neonatal Respiratory Treatment Repellent Market by Country, 2020 - 2026, USD Million
TABLE 7 LAMEA Chronic Obstructive Pulmonary Disease (COPD) Repellent Market by Country, 2016 - 2019, USD Million
TABLE 8 LAMEA Chronic Obstructive Pulmonary Disease (COPD) Repellent Market by Country, 2020 - 2026, USD Million
TABLE 9 LAMEA Acute Respiratory Distress Syndrome (ARDS) Market by Country, 2016 - 2019, USD Million
TABLE 10 LAMEA Acute Respiratory Distress Syndrome (ARDS) Market by Country, 2020 - 2026, USD Million
TABLE 11 LAMEA Other Applications Market by Country, 2016 - 2019, USD Million
TABLE 12 LAMEA Other Applications Market by Country, 2020 - 2026, USD Million
TABLE 13 LAMEA Inhaled Nitric Oxide Market by Country, 2016 - 2019, USD Million
TABLE 14 LAMEA Inhaled Nitric Oxide Market by Country, 2020 - 2026, USD Million
TABLE 15 Brazil Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
TABLE 16 Brazil Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
TABLE 17 Brazil Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
TABLE 18 Brazil Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
TABLE 19 Argentina Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
TABLE 20 Argentina Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
TABLE 21 Argentina Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
TABLE 22 Argentina Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
TABLE 23 UAE Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
TABLE 24 UAE Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
TABLE 25 UAE Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
TABLE 26 UAE Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
TABLE 27 Saudi Arabia Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
TABLE 28 Saudi Arabia Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
TABLE 29 Saudi Arabia Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
TABLE 30 Saudi Arabia Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
TABLE 31 South Africa Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
TABLE 32 South Africa Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
TABLE 33 South Africa Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
TABLE 34 South Africa Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
TABLE 35 Nigeria Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
TABLE 36 Nigeria Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
TABLE 37 Nigeria Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
TABLE 38 Nigeria Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
TABLE 39 Rest of LAMEA Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
TABLE 40 Rest of LAMEA Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
TABLE 41 Rest of LAMEA Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
TABLE 42 Rest of LAMEA Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
TABLE 43 Key Information – Getinge AB
TABLE 44 key Information – Merck Group
TABLE 45 key Information – Halma PLC
TABLE 46 key Information – Linde PLC
TABLE 47 Key information – Air Liquide S.A.
TABLE 48 Key information – Beyond Air, Inc.
TABLE 49 Key information – Mallinckrodt PLC
TABLE 50 Key Information – VERO Biotech LLC
TABLE 51 key Information – Nu-Med Plus, Inc.
TABLE 52 key Information –Novoteris, LLC
List of Figures
FIG 1 Methodology for the research